Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Helena Olearska"'
Autor:
Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the lit
Externí odkaz:
https://doaj.org/article/1254a0f6a8cc42f8becf30fad0bed1c7
Autor:
Marta Opalińska, Anna Sowa-Staszczak, Helena Olearska, Magdalena Ulatowska-Bialas, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundNeuroendocrine neoplasms are a heterogeneous group of cancers that develop from enterochromaffin cells of the diffuse endocrine system, with an increase in incidents over the last years. Ovarian neuroendocrine tumors (NET) are rare neoplasm
Externí odkaz:
https://doaj.org/article/91943ef9e7324292973a1ad795f44e8a
Autor:
Anna Sowa-Staszczak, Marta Opalińska, Anna Kurzyńska, Karolina Morawiec-Sławek, Aleksandra Gilis-Januszewska, Joanna Palen-Tytko, Helena Olearska, Alicja Hubalewska-Dydejczyk
Publikováno v:
Medicina, Vol 57, Iss 12, p 1287 (2021)
Background and Objectives: Long-acting somatostatin analogues (SSA) (octreotide LAR and lanreotide Autogel) are recommended as first line treatment of locally advanced or metastatic well-differentiated neuroendocrine tumors (NETs) with a good express
Externí odkaz:
https://doaj.org/article/d1af90866c104807a5ccfce4df035ce8
Autor:
Helena Olearska, Anna Sowa-Staszczak, Marta Opalinska, Anna Kurzyńska, Alicja Hubalewska-Dydejczyk
Publikováno v:
Endocrine Abstracts.
Autor:
Alicja Hubalewska-Dydejczyk, Helena Olearska, Aleksandra Gilis-Januszewska, Anna Kurzynska, Karolina Morawiec-Sławek, Marta Opalińska, Joanna Ewelina Paleń-Tytko, Anna Sowa-Staszczak
Publikováno v:
Medicina
Medicina; Volume 57; Issue 12; Pages: 1287
Medicina, Vol 57, Iss 1287, p 1287 (2021)
Medicina; Volume 57; Issue 12; Pages: 1287
Medicina, Vol 57, Iss 1287, p 1287 (2021)
Background and Objectives: Long-acting somatostatin analogues (SSA) (octreotide LAR and lanreotide Autogel) are recommended as first line treatment of locally advanced or metastatic well-differentiated neuroendocrine tumors (NETs) with a good express
Autor:
Magdalena Ulatowska-Białas, Aleksandra Gilis-Januszewska, Marta Opalińska, Helena Olearska, Alicja Hubalewska-Dydejczyk, Anna Sowa-Staszczak
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology
BackgroundNeuroendocrine neoplasms are a heterogeneous group of cancers that develop from enterochromaffin cells of the diffuse endocrine system, with an increase in incidents over the last years. Ovarian neuroendocrine tumors (NET) are rare neoplasm
Autor:
Anna Grochowska, Alicja Hubalewska-Dydejczyk, Helena Olearska, Marta Opalińska, Anna Sowa-Staszczak
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the lit